venBio Global Strategic — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data.
AI & Machine LearningBiotechDeep TechChippendale, AU
TIMOTHY CRAVEN(Executive Officer, Director)TOBY PASSIOURA(Executive Officer, Director)Tim Craven(CEO)Toby Passioura(CSO)Glen McIntyre(COO)GLEN MCINTYRE(Executive Officer, Director)
Board seatCorey Goodman· per SEC Form D · $2.3M raise · filed Dec 2023
Co-investorsCivilization Ventures Management, LlcMRL Ventures FundPlayground GlobalvenBio PartnersAxial VC
Boston, US
Board seatCorey Goodman· per SEC Form D · $4M raise · filed Jul 2023
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.